Paediatric (childhood-onset) rheumatologic conditions may be a significant driver of disability in children that might progress into adulthood. Audrey Abella speaks with Associate Professor Thaschawee Arkachaisri, Head and Senior Consultant, Rheumatology and Immunology Service, KK Women’s and Children’s Hospital in Singapore, to discuss how such conditions can be managed in primary care.
Dr. Faith Chia Li-Ann, Dr. Paula P Tjokrosaputro, 20200224180010
Early diagnosis of RA is important such that treatment can be initiated early to prevent joint damage. Senior consultant Dr Faith Chia Li-Ann and senior resident Dr Paula P Tjokrosaputro from the Department of Rheumatology, Allergy and Immunology in Tan Tock Seng Hospital (TTSH), Singapore share their insights with Pearl Toh on the role of GPs in caring for patients with RA in the primary care setting.
Dr Sue-Ann Ng, Associate Consultant at the Department of Rheumatology & Immunology, Singapore General Hospital, speaks to Roshini Claire Anthony on the multisystemic autoimmune disease that is systemic sclerosis (SSc) and the importance of early identification of the condition.
Roshini Claire Anthony speaks with Dr Annie Law, a consultant at the Department of Rheumatology & Immunology, Singapore General Hospital, on how primary care physicians can help in the management of systemic lupus erythematosus (SLE).
A 36-year-old banker with good past health presented to our rheumatology clinic with a 6-month history of bilateral wrist pain. He initially sought medical attention in the private sector for a 2-month history of bilateral symmetrical wrist pain and swelling.
Dr. Priscilla Wong, Dr. Lydia Tam, Prof. LS Tam, 20171110000000
This case report highlights that psoriatic arthritis is a heterogenous disease affecting multiple disease domains, and effective treatment requires thorough assessment of each of these different domains.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Rheumatology digital copy today!
Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.